NIH funding by institute · Fiscal year 2026
National Institute of Neurological Disorders and Stroke (NINDS) Grants and Funding
Reviewed by Dr. Meng ZhaoLast reviewed October 26, 2026Data refreshed October 16, 2026Editorial standards
NINDS administered $2.28B in fiscal year 2026 across 4,057 award records to 242 institutions with $10M or more in NIH funding, up 0.7% from FY2025. Massachusetts General Hospital received the most, 5.6% of that total.
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
FY2026 NINDS funding
$2.28B
+0.7% vs FY2025
Award records
4,057
Institutions funded
242
Recipients with $10M+ in NIH funding
Open or upcoming NOFOs
87
NINDS as lead or participating institute
Top NINDS-funded institutions, FY2026
| # | Institution | NINDS FY2026 | vs FY2025 | Awards | Share |
|---|---|---|---|---|---|
| 1 | Massachusetts General HospitalBoston, MA | $128.7M | +16.7% | 115 | 5.6% |
| 2 | University of California, San FranciscoSan Francisco, CA | $69.7M | −5.4% | 124 | 3.1% |
| 3 | University of PennsylvaniaPhiladelphia, PA | $61.6M | −4.6% | 111 | 2.7% |
| 4 | Yale UniversityNew Haven, CT | $56.2M | +38.6% | 96 | 2.5% |
| 5 | Washington University in St. LouisSaint Louis, MO | $54.3M | −3.7% | 109 | 2.4% |
| 6 | University of MichiganAnn Arbor, MI | $51.5M | −9.3% | 106 | 2.3% |
| 7 | Johns Hopkins UniversityBaltimore, MD | $48.7M | −12.4% | 93 | 2.1% |
| 8 | Stanford UniversityStanford, CA | $47.0M | −15.1% | 79 | 2.1% |
| 9 | Columbia University Health SciencesNew York, NY | $46.6M | −14.9% | 88 | 2.0% |
| 10 | Northwestern UniversityChicago, IL | $45.9M | +25.8% | 78 | 2.0% |
| 11 | Duke UniversityDurham, NC | $42.3M | +64.1% | 63 | 1.9% |
| 12 | University of California San DiegoLa Jolla, CA | $40.8M | −20.0% | 79 | 1.8% |
| 13 | University of PittsburghPittsburgh, PA | $40.0M | −20.7% | 83 | 1.8% |
| 14 | NYU Grossman School of MedicineNew York, NY | $39.2M | −10.3% | 53 | 1.7% |
| 15 | University of California, DavisDavis, CA | $35.4M | +8.7% | 48 | 1.6% |
| 16 | Children's Hospital of PhiladelphiaPhiladelphia, PA | $33.8M | +48.7% | 37 | 1.5% |
| 17 | Emory UniversityAtlanta, GA | $32.8M | +23.6% | 70 | 1.4% |
| 18 | University of MinnesotaMinneapolis, MN | $32.3M | −9.6% | 60 | 1.4% |
| 19 | University of California, Los AngelesLos Angeles, CA | $31.9M | −24.1% | 53 | 1.4% |
| 20 | Weill Cornell MedicineNew York, NY | $31.4M | +42.7% | 49 | 1.4% |
| 21 | UTHealth HoustonHouston, TX | $29.3M | +27.0% | 54 | 1.3% |
| 22 | Icahn School of Medicine at Mount SinaiNew York, NY | $28.2M | +5.9% | 43 | 1.2% |
| 23 | University of FloridaGainesville, FL | $28.2M | −5.9% | 49 | 1.2% |
| 24 | University of Colorado Anschutz Medical CampusAurora, CO | $27.9M | +34.3% | 66 | 1.2% |
| 25 | University of Wisconsin-MadisonMadison, WI | $27.8M | +13.9% | 40 | 1.2% |
Showing the 25 largest of 242 institutions with NINDS funding.
Open and upcoming NINDS funding opportunities
NOFOs led by NINDS first, then those NINDS participates in, soonest due date first. Browse every NIH NOFO.
- Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
PAR-25-149 · U01
Next due Nov 5, 2026
- NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)
PAR-27-065 · UG3, UH3
Next due Nov 9, 2026
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
RFA-NS-26-001 · U01
Next due Nov 10, 2026
- Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
PAR-24-293 · UG3, UH3
Next due Jan 15, 2027
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
RFA-NS-25-023 · R61, R33
Next due Jan 15, 2027
- Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
PAR-25-383 · UG3, UH3
Next due Jan 28, 2027
- Translational Neural Devices (R61/R33 - Clinical Trial Optional)
PAR-25-053 · R61, R33
Next due Jan 28, 2027
- BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)
RFA-NS-28-010 · R01 · opens soon
Next due Feb 8, 2027
- BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
RFA-NS-27-015 · U01
Next due Feb 8, 2027
- Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
PAR-25-327 · U01
Next due Feb 9, 2027
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
PAR-25-215 · K22
Next due Feb 12, 2027
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
PAR-25-216 · K22
Next due Feb 12, 2027
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
PAR-25-225 · R61, R33
Next due Feb 18, 2027
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
PAR-25-059 · R61, R33
Next due Feb 18, 2027
Next due Feb 18, 2027
Showing 15 of 87. See all NINDS NOFOs.
Recent NINDS awards
The newest NINDS award notices among the institutions above, each linked to its NIH RePORTER record.
- Mechanism-guided amelioration of hyperactivity in human and rodent nociceptors linked to spontaneous pain (opens NIH RePORTER)
UTHealth Houston · 1RF1NS144915-01A1 · NINDS · Notice Sep 19, 2026
$2.3MRF1
- Reverse Engineering the Architecture of Inhibitory Synapses at Nanometer Resolution (opens NIH RePORTER)
Scripps Research · 1R01NS148498-01 · NINDS · Notice Sep 19, 2026
$688KR01
- Brain Pericytes in Perinatal Hypoxic-Ischemic Encephalopathy (opens NIH RePORTER)
Loma Linda University · 1R01NS152423-01 · NINDS · Notice Sep 19, 2026
$643KR01
- Dynamic Properties of a Dentate Gyrus Associative Circuit Implicated in Learning and Disease. (opens NIH RePORTER)
Albert Einstein College of Medicine · 1R01NS149182-01A1 · NINDS · Notice Sep 19, 2026
$641KR01
- Resolving MYT1L Variant Heterogeneity Through Cross-Species Molecular Neurogenetics and Drug Discovery (opens NIH RePORTER)
Washington University in St. Louis · 1R01NS152315-01 · NINDS · Notice Sep 19, 2026
$617KR01
- CRISPR/Cas9-Mediated Therapeutic Targeting of CAG Repeats in Spinocerebellar Ataxia Type 12 (opens NIH RePORTER)
Johns Hopkins University · 1R61NS149087-01 · NINDS · Notice Sep 19, 2026
$581KR61
- Dissecting the Cellular and Molecular Mechanisms Underpinning Single Neuron Computation (opens NIH RePORTER)
Stanford University · 1R01NS153223-01 · NINDS · Notice Sep 19, 2026
$532KR01
- Cellular Energy Metabolism in Neurons (opens NIH RePORTER)
Harvard Medical School · 1R01NS153564-01 · NINDS · Notice Sep 19, 2026
$485KR01
- Regulation of Glioma Cell State Transition and Therapy Response by RNA Alternative Splicing (opens NIH RePORTER)
Medical University of South Carolina · 1R21NS148843-01A1 · NINDS · Notice Sep 19, 2026
$189KR21
- Unraveling Mechanisms Governing Cell Clearance Deficits in C9ORF72-ALS/FTD (opens NIH RePORTER)
University of Missouri · 1R56NS140507-01A1 · NINDS · Notice Sep 18, 2026
$539KR56
Looking for a postdoc in neuroscience?
See how many neuroscience labs received a new NINDS R01 or R00 in the last three months, by month, state, and institution.
Newly funded neuroscience labsQuestions about NINDS funding
- How much does NINDS fund?
- In fiscal year 2026, NINDS administered $2.28B across 4,057 award records to the 242 institutions on this page. These are the recipients with $10M or more in total NIH funding, so the figure is a large share of NINDS's extramural awards but not its full budget.
- Which institutions get the most NINDS funding?
- Massachusetts General Hospital ($128.7M), University of California, San Francisco ($69.7M), University of Pennsylvania ($61.6M) led NINDS funding in FY2026.
- How do I find an open NINDS funding opportunity?
- This page lists open and upcoming NOFOs where NINDS is the lead or a participating institute, with the next due date. Most investigator-initiated applications go through the NIH parent announcements instead, and are assigned to an institute after submission; contact a NINDS program officer before you apply to check fit.
More NIH funding rankings
By type
University and health systems
By NIH institute
All institutes · NCI · NIAID · NIA · NHLBI · NIGMS · NIDDK · NIMH · OD · NICHD · NIDA · NCATS · NEI · NIAMS · NIEHS · NHGRI · NIAAA · NIDCD · NIDCR · NIBIB · NIMHD · NCCIH · NINR · NLM · FIC
By state
California · New York · Massachusetts · Pennsylvania · Texas · North Carolina · Maryland · Illinois · Washington · Ohio · Michigan · Florida · Missouri · Connecticut · Georgia · Minnesota · Tennessee · Wisconsin · Virginia · Colorado · New Jersey · Indiana · Oregon · Arizona · Alabama · Utah · Rhode Island · South Carolina · Kentucky · District of Columbia · Louisiana · Iowa · Oklahoma · Kansas · Nebraska · New Hampshire · New Mexico · Maine · Arkansas · Delaware · Mississippi · Vermont · Hawaii · Montana · West Virginia · Puerto Rico · South Dakota · Nevada · Idaho · North Dakota · Alaska · Wyoming